Elsevier’s "ScienceDirect" Articles Surpass Nine-Million Mark
Platform’s Online Content Doubled in Less Than Five Years
Amsterdam, July 14, 2008 - Elsevier, a leading publisher of scientific, technical and medical (STM) information, today announced that its online scientific research platform, ScienceDirect, has surpassed nine million full-text articles.
Doubling its content in less than five years, ScienceDirect is the largest and most extensive online STM research platform. Serving the evolving needs of the global scientific community, the platform offers search, reference and discovery tools to help researchers quickly find the most relevant content for their specific objectives.
“The increasing volume and quality of articles on ScienceDirect continues to make it a high-value asset to the scientific community,” said Rafael Sidi, Vice President, Product Management, ScienceDirect. “The platform’s ability to help find and harness specific knowledge within the growing pool of content is critical.”
The nine millionth article added to ScienceDirect was On the Origin of a Double Oblique Impact of Mars by J. E. Chappelow and R. R. Herrick of Arctic Region Supercomputing Center at University of Alaska Fairbanks. The study, which appears in the journal Icarus, explores how Mars’ Olympus Mons, the largest volcano in the Solar System, was formed.
“I’m happy to participate in this exciting milestone,” said Chappelow. “The growing reach of online articles opens up new opportunities for collaboration, which have helped many researchers to advance their fields of science. My own research has benefited from the multiple contacts I’ve made as a result of online literature searches.”
ScienceDirect serves as host to the scientific research community by creating “peer connections” between scientists and researchers and fostering interactions that allow them to compare and discuss findings and accelerate research. Recent enhancements to the platform also include 2collab, a new collaboration tool that researchers can use to rate and comment on research articles.
# # #
Over a quarter of the world's full text scientific, technical and medical (STM) peer-reviewed articles - managed by renowned editors, written by respected authors and read by researchers from around the globe - are available in one place: ScienceDirect.
Elsevier's extensive and unique full-text collection covers authoritative titles from the core scientific literature including high impact factor titles such as THE LANCET, Cell and Tetrahedron. Over nine million articles are available online, including Articles in Press which offer online access to recently accepted manuscripts. The critical mass of trusted information available on ScienceDirect is unsurpassed. Coverage includes over 2,500 journals published by Elsevier and dynamic linking to journals from approximately 2,000 STM publishers through CrossRef. An expanding program of online major reference works, handbooks, book series and over 4,400 eBooks in all fields of science seamlessly interlinks with primary research referenced in journal articles.
Elsevier is a world-leading provider of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet and Cell, and 25,000 book titles, including major reference works from Mosby and Saunders. Elsevier’s online solutions include ScienceDirect, Scopus, SciVal, Reaxys, ClinicalKey and Mosby’s Suite, which enhance the productivity of science and health professionals, helping research and health care institutions deliver better outcomes more cost-effectively.
A global business headquartered in Amsterdam, Elsevier employs 7,000 people worldwide. The company is part of Reed Elsevier Group PLC, a world leading provider of professional information solutions in the Science, Medical, Legal and Risk and Business sectors, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).
Padilla Speer Beardsley
+1 212 752 8338 ext. 662